A Phase 1/2A Study of Minerval in Adult Patients With Advanced Solid Tumours
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01792310 |
|
Recruitment Status :
Completed
First Posted : February 15, 2013
Last Update Posted : December 6, 2016
|
Sponsor:
Laminar Pharmaceuticals
Collaborators:
Specialized Medical Services (SMS)-Oncology BV
Royal Marsden NHS Foundation Trust
Northern Institute for Cancer Research, Newcastle
Vall d'Hebron Institute of Oncology
Instituto Oncológico IMQ, Clínica IMQ Zorrotzaurre. Bilbao
Onkologikoa, San Sebastián.
Information provided by (Responsible Party):
Laminar Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | September 2016 |
| Actual Study Completion Date : | September 2016 |